G24D (p.Gly24Asp) variant of ABL2 (Tyrosine-protein kinase ABL2)
G24D (p.Gly24Asp) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data and structural context.
G24D (p.Gly24Asp) variant details
- p.Gly24Asp
- NCI-TCGA Cosmic COSV6266
- cosmic curated COSV62666
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.499
- REVEL 0.47
- CADD 25.60
- PolyPhen-2 0.99
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available